Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1-Methyl-5,5-diphenylimidazolidine-2,4-dione

1-Methyl-5,5-diphenylimidazolidine-2,4-dione is listed in the pharmaceutical impurity collection under CAS 6859-11-6. Its represented structure has formula C16H14N2O2 and a calculated molecular weight of 266.30 g/mol.

2D chemical structure

N O N H O

Chemical identity

Catalog name
1-Methyl-5,5-diphenylimidazolidine-2,4-dione
Common name
Not available
Chemical name
1-methyl-5,5-diphenylimidazolidine-2,4-dione
CAS
6859-11-6
SMILES
CN1C(=O)NC(=O)C1(c1ccccc1)c1ccccc1
InChI
InChI=1S/C16H14N2O2/c1-18-15(20)17-14(19)16(18,12-8-4-2-5-9-12)13-10-6-3-7-11-13/h2-11H,1H3,(H,17,19,20)
InChIKey
XJFHNALJPCMIFS-UHFFFAOYSA-N
Associated API
Matrix - API Family Phenytoin Sodium; Phenytoin | Phenytoin; Phenytoin Sodium

Record ID: A8083c06ab45e

Computed properties

C16H14N2O2 Molecular formula
266.3 g/molMolecular weight
266.1055 DaMonoisotopic exact mass
49.41 ŲTopological polar surface area
2.1118 Calculated LogP (Wildman–Crippen)
74.9657 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 3 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight266.334.23
Calculated LogP (Wildman–Crippen)2.111844.63
Topological polar surface area49.4130.69
Hydrogen-bond acceptors215.92
Hydrogen-bond donors138.08
Rotatable bonds (strict)224.16

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC16H14N2O2dimensionless
Molecular weight266.3g/mol
Monoisotopic exact mass266.1055Da
Topological polar surface area49.41Ų
Calculated LogP (Wildman–Crippen)2.1118dimensionless
Molar refractivity (Wildman–Crippen)74.9657cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors1count
Rotatable bonds (strict)2count
Heavy atoms20count
Heteroatoms4count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.125fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area116.5752Ų
Valence electrons100count
Radical electrons0count
Bertz complexity613.1918index
Balaban J2.2955index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1-Methyl-5,5-diphenylimidazolidine-2,4-dione

Qualification and safety assessment of 1-Methyl-5,5-diphenylimidazolidine-2,4-dione

Explore toxicological qualification of 1-Methyl-5,5-diphenylimidazolidine-2,4-dione and ICH M7 mutagenic impurity assessment of 1-Methyl-5,5-diphenylimidazolidine-2,4-dione for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1-Methyl-5,5-diphenylimidazolidine-2,4-dione and acceptable intake and limit justification for 1-Methyl-5,5-diphenylimidazolidine-2,4-dione. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1-Methyl-5,5-diphenylimidazolidine-2,4-dione

Explore Altox services and software through the Altox Pharma-Hub.